Amneal Pharmaceuticals (AMRX)
(Delayed Data from NSDQ)
$7.45 USD
+0.21 (2.90%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $7.45 0.00 (0.00%) 5:22 PM ET
3-Hold of 5 3
A Value A Growth D Momentum A VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO8/9/24 |
---|---|
Current Quarter | 0.14 |
EPS Last Quarter | 0.14 |
Last EPS Surprise | 55.56% |
ABR | 1.80 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 0.58 |
Next Year | 0.60 |
EPS (TTM) | 0.66 |
P/E (F1) | 12.41 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 657.57M | 663.17M | 2.63B | 2.74B |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 662.70M | 666.69M | 2.65B | 2.79B |
Low Estimate | 650.27M | 657.43M | 2.60B | 2.70B |
Year ago Sales | 599.05M | 620.04M | 2.39B | 2.63B |
Year over Year Growth Est. | 9.77% | 6.96% | 9.99% | 4.02% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.14 | 0.14 | 0.58 | 0.60 |
# of Estimates | 3 | 3 | 3 | 3 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | 0.17 | 0.17 | 0.65 | 0.66 |
Low Estimate | 0.11 | 0.10 | 0.49 | 0.51 |
Year ago EPS | 0.19 | 0.19 | 0.64 | 0.58 |
Year over Year Growth Est. | -26.32% | -26.32% | -9.38% | 2.30% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.14 | 0.14 | 0.58 | 0.60 |
7 Days Ago | 0.14 | 0.14 | 0.58 | 0.60 |
30 Days Ago | 0.14 | 0.14 | 0.58 | 0.60 |
60 Days Ago | 0.14 | 0.14 | 0.58 | 0.60 |
90 Days Ago | 0.14 | 0.15 | 0.57 | 0.63 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.14 | 0.14 | 0.58 | 0.60 |
Zacks Consensus Estimate | 0.14 | 0.14 | 0.58 | 0.60 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.14 | 0.14 | 0.19 | 0.19 | NA |
Estimate | 0.09 | 0.07 | 0.12 | 0.10 | NA |
Difference | 0.05 | 0.07 | 0.07 | 0.09 | 0.07 |
Surprise | 55.56% | 100.00% | 58.33% | 90.00% | 75.97% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more